Pharmasaga Co., Ltd.
PrivateLast Round
Pre Seed
Oct 29, 2023
Est. Valuation
$6.82M
Total Funding Raised
$3.72M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Pharmasaga Co., Ltd. is a clinical-stage biotechnology company that develops novel small-molecule drugs for the treatment of diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharmasaga Co., Ltd. Comparables
Compare Pharmasaga Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TIXiMED | 84% | |
| ASAKE Biotechnology, LLC | 81% | |
| Abarceo Pharma | 80% | |
Pharmasaga Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 29, 2023 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Job postings increased from 0 to 3 roles, representing 50% of headcount.
- Mar 2, 2026
Monthly visitors increased 40% MoM, from 559 to 784.
Pharmasaga Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pharmasaga Co., Ltd.'s valuation, stock price, and market status.